Cheng‐Pang Hsu

Optimizing Caco-2 cell monolayers to increase throughput in drug intestinal absorption analysis

Maria Markowska, Rebecca L. Oberle, Steve Juzwin et al. · Journal of Pharmacological and Toxicological Methods · 2001 · 91 citations

Pharmacy, Pharmaceutics, Pharmacology +12

A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Luis Paz‐Ares, Beatrix Bálint, Richard H. De Boer et al. · Journal of Thoracic Oncology · 2013 · 72 citations · Full text

Medicine, Oncology, Pharmacology +12

Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanoma

Robert H.I. Andtbacka, Thomas Amatruda, John Nemunaitis et al. · EBioMedicine · 2019 · 68 citations · Full text

Life Sciences, Immunology, Oncology +16

TRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first‐line treatment of metastatic colorectal cancer

Charles S. Fuchs, Marwan Fakih, Lee S. Schwartzberg et al. · Cancer · 2013 · 65 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +11

Preclinical Pharmacokinetic/Pharmacodynamic Modeling and Simulation in the Pharmaceutical Industry: An IQ Consortium Survey Examining the Current Landscape

Edgar Schuck, Tonika Bohnert, Arijit Chakravarty et al. · The AAPS Journal · 2015 · 51 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17